{
    "2021-05-26": [
        [
            {
                "time": "",
                "original_text": "生长激素龙头长春高新的烦恼：生长激素领域吃独食局面将终结",
                "features": {
                    "keywords": [
                        "生长激素",
                        "长春高新",
                        "龙头",
                        "竞争"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【基金交易日报】博时国泰新基金延长募集，南方聚利大幅溢价50%，嘉实洪流新基金募资40亿元",
                "features": {
                    "keywords": [
                        "基金",
                        "博时国泰",
                        "南方聚利",
                        "嘉实洪流"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "基金"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生长激素集采“迷雾”下，长春高新股价狂跌，董事长紧急增持5700股",
                "features": {
                    "keywords": [
                        "集采",
                        "长春高新",
                        "股价",
                        "增持"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2天市值暴跌超300亿！长春高新火速回应难挽人心，资金在担忧什么？连续下跌",
                "features": {
                    "keywords": [
                        "长春高新",
                        "市值",
                        "下跌",
                        "资金担忧"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "“长高针”纳入集采？长春高新又大跌，后集采时代药企怎么办",
                "features": {
                    "keywords": [
                        "长高针",
                        "集采",
                        "长春高新",
                        "大跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "长春高新大跌基金浮亏78亿元 300多家机构仍前往调研 连续下跌",
                "features": {
                    "keywords": [
                        "长春高新",
                        "基金",
                        "浮亏",
                        "调研"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "安科生物被241家机构调研，这个行业太暴利！",
                "features": {
                    "keywords": [
                        "安科生物",
                        "调研",
                        "暴利"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制剂"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生物制剂带量采购，要来了",
                "features": {
                    "keywords": [
                        "生物制剂",
                        "带量采购",
                        "政策"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "“均瑶系”大东方9倍溢价聚焦“小个子长高”，自身净利率竟不到2%",
                "features": {
                    "keywords": [
                        "均瑶系",
                        "大东方",
                        "溢价",
                        "净利率"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【医药】集采规则与品类多样探索，处方外流再度提振——医药行业月报——看好",
                "features": {
                    "keywords": [
                        "医药",
                        "集采",
                        "规则",
                        "品类",
                        "处方外流"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "政策"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "电鳗快报|董事长增持5700万股 16省联合带量采购成压垮长春高新的一根稻草？",
                "features": {
                    "keywords": [
                        "长春高新",
                        "董事长增持",
                        "带量采购",
                        "16省联合"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制剂"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}